Hypofibrinogenemia can be estimated by the predictive formula in aortic surgery

[1]  A. Usui,et al.  The incidence and risk factors of hypofibrinogenemia in cardiovascular surgery , 2019, General Thoracic and Cardiovascular Surgery.

[2]  M. Kikura,et al.  Four-Group Classification Based on Fibrinogen Level and Fibrin Polymerization Associated With Postoperative Bleeding in Cardiac Surgery , 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[3]  D. Sessler,et al.  Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. , 2015, British journal of anaesthesia.

[4]  J. Freedman,et al.  Evaluation of a Novel Transfusion Algorithm Employing Point-of-care Coagulation Assays in Cardiac Surgery: A Retrospective Cohort Study with Interrupted Time–Series Analysis , 2015, Anesthesiology.

[5]  A. Usui,et al.  IMPACT OF THE INTRAOPERATIVE USE OF FIBRINOGEN CONCENTRATE FOR HYPOFIBRINOGENEMIA DURING THORACIC AORTIC SURGERY , 2015, Nagoya journal of medical science.

[6]  A. Iseki,et al.  Prediction of Plasma Fibrinogen Concentration Just before Weaning from Cardiopulmonary Bypass with Hypothermic Circulatory Arrest in Patients Undergoing Thoracic Aortic Surgery , 2012 .

[7]  L. Cohn,et al.  Point-of-Care Testing: A Prospective, Randomized Clinical Trial of Efficacy in Coagulopathic Cardiac Surgery Patients , 2012, Anesthesiology.

[8]  T. Kuntze,et al.  Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial. , 2010, The Journal of thoracic and cardiovascular surgery.

[9]  R. Salamonsen,et al.  Protocol based on thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: a pilot study. , 2009, Heart, lung & circulation.